are assumed to induce conformational changes, which are the origin of the catalytic activation. At the molecular level, the activation and deactivation mechanisms are unknown, as is the dynamics of NO once in the heme pocket. Using ultrafast time-resolved absorption spectroscopy, we measured the kinetics of NO rebinding to sGC after photodissociation. The main spectral transient in the Soret band does not match the equilibrium difference spectrum of NO-liganded minus unliganded sGC, and the geminate rebinding was found to be monoexponential and ultrafast ( ‫؍‬ 7.5 ps), with a relative amplitude close to unity (0.97). These characteristics, so far not observed in other hemoproteins, indicate that NO encounters a high energy barrier for escaping from the heme pocket once the His-Fe 2؉ bond has been cleaved; this bond does not reform before NO recombination. The deactivation of isolated sGC cannot occur by only simple diffusion of NO from the heme; therefore, several allosteric states may be inferred, including a desensitized one, to induce NO release. Thus, besides the structural change leading to activation, a consequence of the decoupling of the proximal histidine may also be to induce a change of the heme pocket distal geometry, which raises the energy barrier for NO escape, optimizing the efficiency of NO trapping. The nonsingle exponential character of the NO picosecond rebinding coexists only with the presence of the protein structure surrounding the heme, and the single exponential rate observed in sGC is very likely to be due to a closed conformation of the heme pocket. Our results emphasize the physiological importance of NO geminate recombination in hemoproteins like nitric-oxide synthase and sGC and show that the protein structure controls NO dynamics in a manner adapted to their function. This control of ligand dynamics provides a regulation at molecular level in the function of these enzymes.
Guanylate cyclase is involved in signal transduction pathways in which cGMP 1 acts as a second messenger in several types of cells (for reviews, see Refs. [1] [2] [3] [4] . In endothelial cells, sGC is activated by NO produced by the constitutive enzyme nitric-oxide synthase. The binding of NO induces a several hundred-fold increase of the sGC catalytic activity, leading to cGMP production from GTP. This heterodimeric enzyme possesses a heme in the ␤-subunit where NO binding takes place, while the ␣-subunit harbors the catalytic site, which binds the precursor substrate GTP. The second messenger cGMP then triggers the downstream events leading to smooth muscle relaxation.
Regarding diatomic ligand binding, sGC differs from other hemoproteins like myoglobin or hemoglobin; while sGC displays a very high affinity for NO, its affinity for O 2 is very low, but the structural features giving rise to this property are unknown. As in Hb and Mb, the heme iron of sGC is bound to a His side chain (5, 6) but much more weakly. Upon binding of NO to the heme, the His-Fe 2ϩ bond is cleaved, as reflected by the change in Soret absorption position, leading to a fivecoordinate Fe 2ϩ with NO on the distal side. This event is thought to trigger the structural changes that occur in the regulatory ␤-subunit and propagate through the interface between subunits and then lead to the activated conformation of sGC. Furthermore, the protoheme alone enables the activation of sGC depleted in heme independently of NO (7) , showing that, besides the absence of the His-Fe 2ϩ bond, the presence of the heme is essential for maintaining the activated conformation of sGC. When the NO-sGC complex forms from NO in solution, a transient six-coordinate heme occurs before the formation of the five-coordinate activated species (8) .
At the molecular level, many structural features of the protein and mechanisms of its action, such as the nature of the molecular events that follow His-heme bond cleavage, the subsequent activation, and the deactivation processes, remain unknown. Two possible deactivation mechanisms have been hypothesized; the first one involves simple diffusion of NO from the heme pocket (9 -11) and possible subsequent scavenging by an agent like hemoglobin (12) . In a second model, sGC would deactivate before NO release by increasing the rate of NO release through an allosteric transition. The possible action of an endogenous effector is supported by the observation that deactivation occurs faster in whole cells (13) or in cytosol preparations (14) than it does in the isolated enzyme. The nature of this possible effector has been the subject of different hypotheses. The substrate or the product cGMP itself could bind close to the heme, exerting a feedback action (15) ; alternatively, a proteic factor (16) might directly interact with either subunit, although it would act on a different time scale from that of NO diffusion from the heme. The action of proteins must be regulated at different levels and on different time scales. In the case of nitric-oxide synthase, physiological regulation occurs at the level of gene expression and/or via effectors binding, but such mechanisms for sGC still await demonstration. However, regulation mechanisms at the molecular level, by means of the control of ligand dynamics on the ultrafast time scale are necessary and expected. More specifically, the control of NO dynamics in the vicinity of the heme, including binding and release, may be involved in the physiological regulation of sGC activity. To investigate these points, we measured the kinetics of NO rebinding after photodissociation by using time-resolved absorption spectroscopy in the picosecond range. This allows the probing of the dynamics of NO when sGC is in the activated state.
EXPERIMENTAL PROCEDURES
Purification of Guanylate Cyclase-We purified sGC from bovine lung using a modified method from Mulsch and Gerzer (17) and Stone and Marletta (18) . All steps were performed at 4°C. One kg of bovine lung was homogenized in 1 liter of buffer (25 mM TEA, pH 7.4, 50 mM NaCl, 5 mM DTT, 1 mM phenylmethylsulfonyl fluoride, 1 mM EDTA, 1 mM benzamidine, 1 M pepstatin A, 1 M leupeptin, 1 M aprotinin). The homogenate was centrifuged at 40,000 ϫ g for 30 min. The supernatant was filtered through eight layers of gauze and then centrifuged again at 40,000 ϫ g for 2 h. One liter of this surpernatant was loaded by means of a peristaltic pump (3 ml/min) onto a column (2.5 cm ϫ 90 cm) containing Q-Sepharose Fast Flow (Sigma) previously equilibrated with homogenizing buffer. The column was then washed with two volumes of the same buffer. All of the following chromatographic steps were performed using an Akta Purifier FPLC system (Amersham Pharmacia Biotech). The column was eluted with a linear gradient from 50 to 400 mM NaCl (flow 2.5 ml/min). The elution profile was continuously monitored for absorption at 280, 430, and 460 nm as well as for pH and conductivity. The fractions (10 ml each) were assayed for cyclase activity (see below), and the active ones were pooled and diluted 3 times in buffer without NaCl to get about 85 mM NaCl.
This solution (about 220 ml) was then loaded onto a high resolution anion exchange column (Source 30Q; 2.6 ϫ 30 cm; Amersham Pharmacia Biotech), which was subsequently washed with two volumes of buffer A (25 mM TEA, pH 7.4, 50 mM NaCl, 5 mM DTT, 0.1 mM phenylmethylsulfonyl fluoride, 0.2 mM benzamidine). The proteins were eluted by means of a linear gradient from 50 to 400 mM NaCl (2.5 ml/min). The 10-ml fractions were assayed for GMP cyclase activity. The more active ones were pooled (60 ml in total) and concentrated in a stirring concentrator with a 50-kDa cut-off membrane (Millipore Corp.) under argon at a positive pressure of 1 bar. The solution was supplemented with additional DTT (5 mM), and 8 ml were injected onto a high resolution gel filtration column (Superdex 200pg; Amersham Pharmacia Biotech; 2.6 ϫ 60 cm), from which proteins were separated using an isocratic elution with buffer A at a flow rate of 1 ml/min. The active fractions (25 ml in total) were concentrated in a centrifugation device with a 50-kDa cut-off membrane (Ultrafree-15; Millipore) to 3 ml. The buffer A was exchanged for buffer G (same as buffer A but without NaCl and containing 5 mM MnCl 2 ).
This last solution concentrated to 1.5 ml was loaded into a GTPagarose affinity column (2.6 ϫ 3 cm; Sigma) equilibrated with buffer G, which was immediately eluted (0.5 ml/min) with a linear gradient from buffer G to buffer C (25 mM TEA, pH 7.4, 6 mM ATP, 50 mM NaCl, 5 mM DTT, 0.1 mM phenylmethylsulfonyl fluoride, 0.2 mM benzamidine). The purified sGC was eluted as a single peak at 62% of buffer C (about 3.7 mM ATP). The active fractions (9 ml) are pooled and concentrated to 50 l. For spectroscopic measurements, the buffer was exchanged for only 25 mM TEA, 50 mM NaCl, pH 7.5, by means of successive dilutions and centrifugations in order to obtain less than 50 nM ATP and DTT. The specific activity (see below) was measured, and the presence of two bands at 72-75 kDa was checked on 7.5% polyacrylamide-SDS electrophoresis.
The Q-Sepharose fast flow chromatography allowed the rapid processing of a large amount of crude supernatant, and the very high resolution anionic exchange medium for the second step was found to be more efficient than the use of blue Sepharose. The GTP affinity medium was progressively degraded by sGC and was used only twice. The ultrafast kinetic measurements were completed within 4 days following the last column elution.
Measurement of Guanylate Cyclase Activity-The activity of sGC in the fractions was measured after each column. In a first step, cGMP was synthesized by sGC from GTP, based on the method proposed by Mulsch and Gerzer (17) , and then the cGMP is assayed by immunodetection using a commercial kit and 96-well microtitration plates (RPN 226; Amersham Pharmacia Biotech).
The incubation buffer for cGMP formation contained 100 mM TEA, pH 7.4, 0.1 mM EGTA, 1 mM DTT, 3 mM MnCl 2 , 0.2 mM GTP, 5 mM creatine phosphate, 150 units/liter creatine phosphokinase, 1 mM isobutylmethylxanthine, 0.1 mM sodium nitroprusside. An aliquot (5 or 10 l) of the fractions to be assayed was mixed with 90 l of this buffer previously warmed at 37°C. Incubation was performed for 10 min and then stopped by placing the tubes on ice and immediately adding 400 l of zinc acetate followed by 500 l of Na 2 CO 3 . The precipitate was separated by centrifugation at 4°C (10 min, 14,000 rpm), and 10 l of the supernatant were put in polypropylene tubes for acetylation simultaneously to the cGMP standards (2-512 fmol of cGMP) and diluted with buffer to 500 l. All of the samples were then acetylated by adding 50 l of acetic anhydride/triethylamine (33:67 mixture), and then 50 l of the acetylated samples were deposited into the wells of the antibodycoated microtitration plate. The manufacturer's instructions were followed for the subsequent steps.
The protein content was assayed by means of the bicinchoninic acid method (Pierce) adapted for a microtitration plate with bovine serum albumin as a standard. We obtained specific activities of 1.2 Ϯ 0.3 mol of cGMP/min/mg of protein in the presence of Mn 2ϩ (3 mM) and 0.1 mM sodium nitroprusside.
Preparation of Samples for Spectroscopy-An aliquot of sGC solution (70 l at about 30 -50 M) was put in a 1-mm optical path length quartz cell sealed with a rubber stopper and degassed with four cycles of vacuum and purging with argon (99.9999%; Alphagaz). Since sGC is purified directly in its ferrous state, it was not necessary to add any reducing agent; however, we verified that no change occurred in the Soret band upon the addition of sodium dithionite. For preparing NOliganded sGC, 1 Ϯ 0.02% NO diluted in N 2 (Alphagaz) was directly introduced into the spectroscopic cell through the gas train at a total pressure of 1.3 bar (about 20 M NO in the aqueous phase), and a second stopper (silicone) was stacked on the cell; for CO-liganded sGC, we used 100% CO (Alphagaz). Equilibrium spectra were recorded at each step for monitoring the evolution of the Soret band. Horse heart myoglobin (80 M) was prepared from lyophilized powder (Sigma) dissolved in 50 mM Tris, pH 7.5, and reduced with sodium dithionite.
Time-resolved Spectroscopy-Time-resolved spectroscopy was performed with the pump-probe laser system previously described (19) . Photodissociation of NO was achieved with an excitation wavelength in the ␣ band at 560 nm with a pulse duration of 40 fs and a repetition rate of 30 Hz. The transient absorption after a variable delay was probed with a wide spectrum pulse from a continuum, whose group velocity dispersion was minimized at 415 nm by double path in a line of prisms. The same sample quartz cell (1-mm optical path length) was used for recording equilibrium spectra and for kinetics, and the absorbance of samples was in the range 0.2-0.6 at the maximum of the Soret band. The sample was continuously moved perpendicularly to the laser beam during the recording, and the temperature was 18°C. Time windows of 6, 20, and 100 ps were scanned, and up to 80 scans were recorded and averaged with a dwell time of 2 s at each point. Analysis of the data was performed by singular value decomposition (SVD) of the time-wavelength matrix (20) , and the kinetics associated with the SVD components having the highest singular value were fit with a minimum number of exponential components. Recording of NO-liganded reduced myoglobin kinetics was performed under identical conditions.
RESULTS
The equilibrium spectrum of unliganded sGC under argon is displayed in Fig. 1A . The enzyme is purified with the heme in the reduced form and reveals a characteristic absorption maximum at 431.5 nm. After the addition of 1% NO, the Soret band immediately shifts to 399 nm upon formation of the NO-fivecoordinate species, and the difference spectrum shows a maximum and a minimum located at 434 and 397 nm, respectively.
The raw difference spectra at successive time delays after photolysis of NO are displayed in Fig. 1B . Two main features are observed: 1) the maximum of induced absorption centered at about 426 nm and the minimum of bleaching at 395 nm decrease without shifting, within the spectral resolution, and 2) a shift of the isosbestic point occurs within 4 ps from ϳ408 to 405 nm. A similar shift also appears around 460 nm in the same time range. These shifts indicate that excited state species are involved in the early time kinetics.
We performed an SVD of the time-wavelength matrix, which resulted in two spectral components (Fig. 1C) . The main component (SVD1) corresponds to geminate recombination, as shown by the decrease of the bleaching at 395 nm, due to the five-coordinate Fe 2ϩ -NO formation. The second spectral component (SVD2; Fig. 1C ), whose intensity is lower, is associated with the decay of the excited states of photodissociated heme, as has been identified in the case of hemoglobin and myoglobin (21). The higher rank SVD components contained only contributions considered as noise within the resolution of the experiment.
The kinetics associated with the SVD1 component, which corresponds to NO geminate recombination ( Fig. 2A) , was fit to a monoexponential function ( ϭ 7.5 ps; A ϭ 0.97 Ϯ 0.01) with a very low base line (A 2 ϭ 0.03), revealing a very fast and almost complete rebinding of NO. The comparison with NO rebinding to Mb, which follows biexponential kinetics, and to endothelial nitric-oxide synthase, which is still unliganded after 50 ps, reveals the differences of the control of the NO dynamics by the three proteins. The transient spectrum after 2 ps following dissociation of NO is compared with that of wild type myoglobin (Fig. 2B) , which reveals the maximum absorption and a minimum of bleaching at 438 and 418 nm, respectively, while sGC shows these features located at 426 and 395 nm, indicating that the coordination state of the heme-iron is different for both proteins at 2 ps.
We measured the rebinding of CO to sGC in order to compare it with its behavior in Mb. The equilibrium spectra of unliganded and CO-liganded sGC are shown in Fig. 3A (inset) together with the kinetics. CO binding results in an absorption spectrum with a maximum at 424 nm, similar to MbCO. The kinetics reveal the presence of two excited state transients (associated with a 0.9-ps rise and a 3-ps decay in the first time window) and a long lived unliganded ground state sGC ( Ͼ 5 ns). Clearly, CO does not rebind to sGC on a short time scale, similarly to myoglobin. Remarkably, the transient difference spectra are similar for Mb and sGC (Fig. 3B) , and both are superimposable with the unliganded minus CO-liganded equilibrium difference spectra, showing that the coordination states are identical in both cases.
We made attempts to remove liganded NO from sGC by means of several vacuum-argon cycles for scavenging NO. The absorption at 399 nm did not decrease even after 24 h. We then tried to replace NO by CO (100% CO, 1.4 bar in the gas phase) in the same sample. Only a very small shoulder appeared around 420 nm, with no significant decrease of the absorption at 399 nm. We then photodissociated NO in the laser beam in the presence of 100% CO for 2 h (at 30 Hz; 18°C), but no subsequent evolution of the steady-state spectrum was observed. Further degassing led FIG. 1. A, absolute and difference equilibrium spectra of ferrous sGC in TEA buffer, pH 7.4. The solid line is the spectrum of the unliganded protein, the dotted line represents the NO-liganded species, and the dashed line is the difference. B, transient spectra (raw data) at different time delays after photodissociation of NO. C, spectral components obtained from SVD analysis. The SVD1 component (solid line) corresponds to the NO rebinding and is compared with the equilibrium difference spectrum (dotted line). The SVD2 component (dashed line) is that of the excited state evolution.
FIG. 2.
A, kinetics of NO rebinding to sGC associated with the SVD1 spectral component (Fig. 1C) to the disappearance of the shoulder due to CO but only to a very small decrease of the Soret band due to NO-liganded species. This shows that the affinity for NO is such that it cannot be removed quickly by diffusion, when removing free NO, or competing with CO.
The spectra of the excited states constitute markers of the heme-iron coordination state. We thus measured the kinetics of reduced unliganded sGC in order to compare its excited state spectrum with that of the five-coordinate heme in Mb and with that of sGC after NO and CO photodissociation. The results are shown in Fig. 4 , and the evolution of the differential spectrum for unliganded sGC is presented in Fig. 4A as raw data, similar to data previously reported for Mb (21, 22) and similar to the spectral evolution of the unliganded oxygen sensor FixL that we also recorded. While the main SVD component is the spectral evolution of an excited state for unliganded proteins (Fig.  4B) , in the case of liganded sGC, the second SVD spectral component corresponds to an excited state species decaying in 2 and 3.2 ps, respectively, after NO and CO photorelease (Fig.  4C) ; SVD1 is geminate rebinding in this case. This spectrum is identical for both unliganded proteins, with a maximum of induced absorption located at 445 Ϯ 1 nm. When sGC is liganded with CO, the photodissociation produces an excited state whose spectrum is similar to that of unliganded proteins (Fig.  4, B and C) , whereas the photodissociation of NO leads to a different spectrum with a maximum at 434 nm and two absorption bands developing below 400 nm and above 440 nm. The bleaching around 410 nm should thus be due to the appearance of a ground state heme. This SVD2 differential spectrum evolves with a time constant of 2 ps, close to the values observed (21) for the decay of an excited state assigned to the heme still being in a near planar conformation.
DISCUSSION
Intermediate Species and Coordination State-The binding of NO induces the breaking of the His-Fe 2ϩ bond, which is hypothesized to be the first molecular event leading to activation of sGC through structural changes. A major question is the reversibility of this process and its consequences for the deactivation of sGC. If only NO diffusion from the heme pocket to the solvent allows a fast deactivation, the dissociation of NO would lead to reformation of the His-Fe 2ϩ bond; consequently, a His-five-coordinate heme and a six-coordinate intermediate 
FIG. 4.
A, transient differential spectra of relaxing unliganded ferrous sGC at given time delays after photoexcitation (raw data). The conditions are the same as for Fig. 1 . B, normalized spectral components from SVD analysis for unliganded sGC (solid line) and Mb (dotted line). They correspond to excited state species that decay with a fitted time constant of 4.2 ps for sGC and 4 ps for Mb. The associated kinetics determined by SVD are shown in the inset. The interval of sampling time is 100 fs. C, spectral components as in B, but for sGC liganded with CO (solid line) and NO (dotted line).
species would be involved in the transient spectra.
There are at least two species involved in the raw differential spectra (Fig. 1B) , as shown by the shift of the isosbestic points, which give rise to two SVD spectral components (Fig. 1C) . The major component corresponds to NO rebinding to a ground state species, while the second corresponds to the disappearance of an excited species. Since the spectra of the four-coordinate heme species are not known, either in the excited or in the ground state, we compared the major spectral feature with that obtained from systems possessing a heme that cannot form a transient proximal fifth coordination after photodissociation. We have measured the kinetics and spectra of NO rebinding to the H93G mutant of myoglobin, 2 which lacks the coupling coordination between the proximal His and the iron (23, 24) . Hemoproteins lacking such a proximal side chain are liganded with a water molecule in the absence of NO (25, 26) . However, Decatur et al. (27) have shown by Raman spectroscopy that H93G-Mb is not six-but five-coordinate in its NO-liganded steady state, in agreement with a Soret position at 400 nm. Consequently, this mutant becomes four-coordinate immediately upon photodissociation and cannot form a His-five-coordinate species before NO rebinding. We found that both the four-coordinate Mb mutant and sGC show a raw transient difference spectrum after NO photodissociation similarly shifted with respect to that of wild type Mb, suggesting identical coordinated heme intermediates for both proteins during the first picoseconds. Therefore, we assigned the transient spectrum characterized by a 7.5-ps decay time and an absorption band centered at 426 nm (Fig. 1B) to the rebinding of NO to a four-coordinate ground state heme. A spectrum similar to that of sGC was observed for two wild type myoglobin species at low pH (28), a condition that leads to the breaking of the Fe 2ϩ -His bond and to the lack of proximal ligation after photodissociation of NO; a broad induced absorption appears centered between 424 and 428 nm and assigned to the transient four-coordinate heme.
The kinetics of NO binding from the solution measured by stopped flow (8) clearly reveal the presence of a six-coordinate intermediate absorbing at 420 nm before the formation of the final NO-five-coordinate activated form. Furthermore, this study revealed that the conversion from six-to NO-five-coordinate heme is 10 3 times slower than the initial binding step. Thus, the conversion of six-to five-coordinate heme subsequent to NO recombination is unlikely to occur on the picosecond time scale.
If the histidine would rebind before NO, we should observe both His-five-and His-six-coordinate intermediate species. In this case, there should be a differential spectral transient with a bleaching at 400 nm simultaneous to an induced absorption around 420 nm, characteristic of six-coordinate heme as detected by Zhao et al. (8) , and another one with an induced absorption located around 431 nm. We did not observe such transients associated with His rebinding, but we found only one spectral feature corresponding to NO rebinding to a ground state species absorbing at 426 nm. These data support the assignment of NO rebinding directly to a four-coordinate heme.
The transient spectrum of the unliganded sGC is identical to that of Mb and evolves with the same kinetics (Fig. 4B) . This observation shows that the early relaxation of heme excited states is not influenced by the protein core and that the coordination of the iron is the same in both excited unliganded proteins, an expected result, since both are five-coordinate in the ground state. Furthermore, the excited state of sGC after CO photodissociation discloses a spectrum similar to that of the unliganded proteins with a maximum at the same position, indicating that the coordination is the same, in agreement with the His-heme remaining bound in the presence of CO. However and importantly, the NO-photodissociated excited heme of sGC discloses a very different transient spectrum (Fig. 1C) , indicating that the coordination state is different, thus corresponding to that of a four-coordinate species.
For Hb and Mb, it was shown (21) that the unliganded excited states decay in 2.5 ps, whatever the photodissociated ligand, evolving directly to liganded ground state. Thus, similarly to Hb, it is likely that in sGC NO rebinds simultaneously both to the excited state heme and to the already relaxed ground state heme.
Origin of the Monoexponential Rebinding-The geminate recombination of diatomic ligands to the heme represents the intramolecular steps of binding, not influenced by NO diffusing from the solvent, and thus allows the probe of the intramolecular factors determining k on . The ligand explores the protein structure before rebinding, and the relative amplitudes of the rebinding phases are highly sensitive to the barriers encountered by the ligand from and to the heme site. Rebinding to the heme may occur directly from the heme pocket or from a more distal location in the protein, as shown by the nanosecond rebinding of NO measured in the case of nitric-oxide synthase (29) . The picosecond rebinding, always observed with two exponential components in hemoproteins so far investigated (not including excited states), is considered to correspond to the rebinding of NO still in the heme pocket. On the contrary, in sGC the 7.5-ps kinetics of NO recombination to the heme is single-exponential. In other systems where the heme is fourcoordinate after photolysis, the fast component is predominant, but the overall ps geminate rebinding always remains biexponential. For the myoglobin mutant H93G, the lack of the proximal His bond leads to an increase of the relative amplitude of the fast phase (11-14 ps; A ϭ 0.63) of NO recombination to the four-coordinate iron. 2 This contrasts with the case of sGC, which also discloses a four-coordinate iron after photodissociation, showing that the monoexponential character of NO geminate rebinding in sGC is due to structural features in the distal side of the heme pocket and not to the iron configuration. Furthermore, the rebinding of NO to protoheme takes place in 7.5 ps (28, 30) without a slower picosecond component, but with a constant base line, which corresponds to the NO escape into the solvent and whose amplitude depends upon the solvent composition (30) . The effect of the heme surroundings on the relative ratio of both picosecond phases is further illustrated by the system calmodulin-heme (31), which allows simultaneously a faster rebinding and a lower bimolecular escape of CO. Together with these observations, our data allow us to draw features of the picosecond geminate recombination.
We assume that the picosecond NO rebinding is governed by two different energy barriers which determine the probability of NO to be in the heme distal pocket and the probability of bond formation once NO is in the pocket, respectively. The first barrier relies only on structural features of the distal pocket and protein structure, and the second one appears affected by the electronic state of the iron (redox and/or coordination) and its position in the heme plane. This view applies for nitric-oxide synthase, to which NO rebinds also in its oxidized state (29) . In this latter case, the change of the redox state of the heme from Fe 3ϩ to Fe 2ϩ induces a decrease of the rate of the fastest picosecond component, but the relative amplitude is not significantly changed. In the case of sGC, this probability is maximized, as reflected by the ultrafast picosecond rebinding; this effect may be assigned to the in-plane position of the four-coordinate iron. It was indeed pointed out that NO rebinds faster to a cobalt-substituted heme Mb (32) for which the cobalt atom remains in the heme plane after photodissociation, but still in a biphasic fashion. On the contrary, mutations in the distal heme pocket of myoglobin have greater effects upon the picosecond rate than the position of the metal atom does, and the rebinding remains biexponential whatever the mutation (32, 33) . From the measurements on various hemoproteins, mutants, and protoheme in different surroundings and states, we conclude that the position of the iron in the heme plane does not influence the slower phase (100 -200 ps), which is only influenced by the protein structure.
The high relative amplitude of the fast geminate recombination, close to unity (0.97), clearly indicates that in sGC the main factor maximizing the recombination comes from the protein structure itself; NO rebinds directly from the heme pocket due to a high energy barrier for escaping. Some distal Mb mutants like V68A and V68F (32, 33) disclose an almost complete or complete picosecond rebinding, while others like V68I (32) or a triple mutant (34) show a base-line amplitude due to the escape of NO from the pocket much larger than the wild type Mb. This dramatically emphasizes the role of the distal heme pocket structure, which leads in sGC to maximize the probability of NO interaction with Fe 2ϩ as shown by the very low base line (0.03), and it is plausible that the breaking of the iron-His bond, simultaneously to triggering the enzymatic activity, also changes the geometry of the heme pocket toward a more closed conformation, lowering the escape rate. This hypothetical closing of the distal side is supported by the observation that imidazole binds at the proximal side of the heme after NO ligation (35) and deserves further investigation.
Recombination of CO with sGC-The activation of purified sGC by 100% CO is very low, only 3-5-fold (18, 36) even if sGC is saturated at such a CO concentration, and the K D of CO binding to sGC is 0.1 mM, which is much higher (ϳ2000-fold) than for Hb and Mb. The contributions for this lower affinity are a 10-fold decrease for k on and a 200-fold increase for k off with respect to Mb, as measured by stopped flow (18) . These values point out the different geometry of the heme pocket in sGC compared with Mb and particularly a lower energy barrier for CO escape, suggesting an open pocket, while the lower k on for CO, together with the nonbinding of O 2 (K D Ͼ 1 mM), suggests particular features on the protein surface. Our observation that 100% CO is not able to displace NO bound to sGC, even after removing free NO, is consistent with this very low affinity. The absence of CO recombination in the picosecond range is in agreement with a fast off rate and with the absence of coordinate intermediate in the CO-sGC interaction. The open character of the heme pocket inducing a fast CO escape, together with the high energy barrier for NO escape and its fast rebinding without a nanosecond phase, leads to the hypothesis of a change in the distal environment following the breaking of the proximal His bond.
Implications for Guanylate Cyclase Activation and Deactivation-sGC discloses a fast monoexponential NO geminate rebinding rate that is unusual and not observed for other hemoproteins. This unique feature provides sGC with an optimized functional adaptation; since NO is reactive and highly diffusive, its concentration must be controlled and as low as compatible with its action in the cell. Once bound to the regulatory part of sGC, NO does not diffuse out of its site. This is in sharp contrast with the endothelial nitric-oxide synthase, in which the proportion of nanosecond rebinding is greater than 0.5 (29) and for which the produced NO must be released in a controlled manner. The NO off rate appears 5-10-fold higher for sGC than for Mb (9, 11), but the geminate rebinding kinetics of these proteins show an opposite trend than their off rate. The comparison of these three hemoproteins ( Fig. 2A) emphasizes the influence of both the protein core and the heme pocket structure on the rebinding and the adaptation of the control of ligand dynamics to their function.
From the unliganded resting state, the binding of NO from solution to sGC leads to a transient six-coordinate complex absorbing at 420 nm as detected by stopped flow (8) , before the formation of the NO-five-coordinate activated state. However, from the liganded activated state, the dissociation of NO from the heme does not immediately lead to His rebinding. As disclosed by the transient spectra, even if the iron moves back in the heme plane, the simple breaking of the NO-Fe 2ϩ bond is not sufficient for reforming the His-Fe 2ϩ before NO recombination. The His rebinding thus occurs on a longer time scale than does NO, precluding reversible change before complete NO release from sGC. The structural changes leading to the catalytic activation may include steps that cannot be simply reversed by rupture of the NO-Fe 2ϩ bond. After cleavage of the His-Fe 2ϩ bond triggered by NO ligation, an imidazole molecule can take its place at the proximal side of the heme pocket (35) , showing that indeed structural changes are induced. The very large binding rate constant is almost diffusion-limited (k on Ͼ 1.4 ϫ 10 8 M Ϫ1 ⅐s Ϫ1 ; Ref. 8), revealing a low energy barrier for binding. On the other hand, the monoexponential ultrafast rebinding reveals a high barrier for NO escape, and the structure of the protein core determines the parameters of the rebinding. These observations are consistent with a closing of the heme distal pocket induced by the His-Fe 2ϩ bond cleavage. The activation of sGC involves tertiary structural changes, and this information must propagate through the interface between subunits; these structural motions have been shown (37) to take place on a much slower time scale than 7 ps. Furthermore, after the decoupling of His and heme followed by protein relaxation, there should be no longer influence of the iron configuration upon the overall structure and the geometry of the heme pocket in the activated state. Then the trapping of NO must be followed by a mechanism promoting deactivation.
The simplest deactivation process of sGC would be the migration of NO out of the protein following dissociation from the activated conformation. Such a scenario is sustained by the in vitro NO scavenging effect of Hb on cytosol (14) , on cells (13) , and on the purified sGC (9, 11) . In the later case, the rate constant of NO dissociation increased 35-fold in presence of Hb; however, this is not fast enough to account for deactivation in cell. The efficient trapping of NO by sGC, resulting from an almost complete geminate rebinding in a few picoseconds, does not support such a mechanism of deactivation. Consequently, the sGC-NO interaction cannot be described by a simple equilibrium between two structural species; the deactivation process must be accompanied by a structural relaxation of the protein to accelerate NO release, and the deactivation does not appear to follow the reverse pathway of the activation process.
The sGC may undergo a cycle through several states, including a possible desensitized state. An allosteric transition of the heme pocket may be hypothesized, either due to spontaneous desensitization or possibly assisted by an endogenous effector, such as a peptide separated from sGC during purification (16) . Another possible effector would be the product cGMP, allowing a feedback regulation. However, under conditions of cGMP accumulation, Mg 2ϩ -GTP does not exert a significant effect on k off (11) or on the rate of cGMP synthesis itself (14) . Consistently, we did not observe an effect of cGMP (in absence of Mg 2ϩ ) upon the geminate rebinding. The action of cGMP may be indirect, occurring via a kinase; indeed, there exist in sGC six phosphorylation sites specific for cGMP-dependent kinase.
An in vivo study monitoring arterial pressure in rat (38) suggests that the blood pressure increase following transfusion of hemoglobin solution is not due to NO scavenging. Furthermore, the deactivation occurs faster in whole cell (13) or in cytosol (14) than it does for the isolated sGC when free NO is trapped by HbO 2 . This is consistent with NO trapping and with an allosteric process in vivo that induces NO release.
Another observation could be explained by allostery; sGC is activated by the benzyl-imidazole derivative YC1 alone (36, 39) without binding to the heme. Furthermore, this compound acts synergistically with CO. This strongly suggests the possibility of an allosteric regulation of the population of the activated state of sGC. Thus, the question of physiological effectors activating or inhibiting sGC at a regulatory site is open.
Conclusion-Our data show that the deactivation of sGC is not achieved only by simple diffusion of NO from the heme and that a change of the allosteric state of the protein must be inferred. The structural features of sGC make it not only a nitric oxide receptor but also an efficient trap for NO as revealed by the ultrafast monoexponential NO geminate recombination, which is very different from that of the other hemoproteins. This efficient trapping, together with the 100-fold activation, allows an amplification of the response at low NO concentration. The coordination state of the heme-iron contributes to increase the recombination probability, but it is not sufficient for getting a single ultrafast picosecond rebinding phase. More importantly, the structure of the heme pocket is optimized both for a low energy barrier of association and for a high barrier of NO escape, controlling the behavior of NO in the picosecond range. Thus, the regulation of a ligand-binding hemoprotein like sGC is determined at the molecular level by the control of the ultrafast ligand dynamics.
